Cite
MLA Citation
A. Wollenberg et al.. “Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).” British journal of dermatology, vol. 182, 2020, pp. 1120–1135. http://access.bl.uk/ark:/81055/vdc_100102778027.0x000059